Eupatilin (CAS: 22368-21-4)

掲載日情報:2018/09/26 現在Webページ番号:52167

AdipoGen社のEupatilin (CAS: 22368-21-4)です。
AdipoGen社は高品質な低分子化合物、希少な抗生物質、天然物などを販売しています。生理活性や阻害効果を有する物質も多数取り揃えております。

本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2024年04月26日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Eupatilin
2週間程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
説明文
Selective inhibitor of 5-lipoxygenase. Apoptosis and cell cycle arrest inducer. Anticancer compound. Inhibits ERK1/2, JNK, and NF-kappaB activation and expression of Raf-1 and Ras. Anti-proliferative compound. Anti-inflammatory and immunosuppressive. Anti-apoptotic compound in hepatocytes. Antioxidant. Antidiabetic. Enhances hepatic and plasma glucose metabolism and increases insulin secretion in type 2 diabetic mice. Inhibits angiogenesis by blocking STAT3 and VEGF expression. Neuroprotective. PI3K Class I, MKK3/6 and MKK4 inhibitor.。由来:Artemisia sp.,M.W.:344.3,純度:>98% (HPLC),化学式:C18H16O7,形状:solid,溶解性:Soluble in DMSO, hot methanol or mixture of methanol, chloroform.,CAS:22368-21-4,M.W:344.3
CAS No:22368-21-4
別名:5,7-Dihydroxy-3',4',6-trimethoxyflavone,NSC 122413
別包装品 別包装品あり
法規制等
保存条件 -20℃,暗所保存,乾燥状態(デシケータ内)で保存 法規備考
掲載カタログ

製品記事 AdipoGen社の低分子化合物
関連記事
Eupatilin
2週間程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
説明文
Selective inhibitor of 5-lipoxygenase. Apoptosis and cell cycle arrest inducer. Anticancer compound. Inhibits ERK1/2, JNK, and NF-kappaB activation and expression of Raf-1 and Ras. Anti-proliferative compound. Anti-inflammatory and immunosuppressive. Anti-apoptotic compound in hepatocytes. Antioxidant. Antidiabetic. Enhances hepatic and plasma glucose metabolism and increases insulin secretion in type 2 diabetic mice. Inhibits angiogenesis by blocking STAT3 and VEGF expression. Neuroprotective. PI3K Class I, MKK3/6 and MKK4 inhibitor.。由来:Artemisia sp.,M.W.:344.3,純度:>98% (HPLC),化学式:C18H16O7,形状:solid,溶解性:Soluble in DMSO, hot methanol or mixture of methanol, chloroform.,CAS:22368-21-4,M.W:344.3
CAS No:22368-21-4
別名:5,7-Dihydroxy-3',4',6-trimethoxyflavone,NSC 122413
別包装品 別包装品あり
法規制等
保存条件 -20℃,暗所保存,乾燥状態(デシケータ内)で保存 法規備考
掲載カタログ

製品記事 AdipoGen社の低分子化合物
関連記事

[在庫・価格 :2024年04月26日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Eupatilin

文献数: 0

説明文 Selective inhibitor of 5-lipoxygenase. Apoptosis and cell cycle arrest inducer. Anticancer compound. Inhibits ERK1/2, JNK, and NF-kappaB activation and expression of Raf-1 and Ras. Anti-proliferative compound. Anti-inflammatory and immunosuppressive. Anti-apoptotic compound in hepatocytes. Antioxidant. Antidiabetic. Enhances hepatic and plasma glucose metabolism and increases insulin secretion in type 2 diabetic mice. Inhibits angiogenesis by blocking STAT3 and VEGF expression. Neuroprotective. PI3K Class I, MKK3/6 and MKK4 inhibitor.。由来:Artemisia sp.,M.W.:344.3,純度:>98% (HPLC),化学式:C18H16O7,形状:solid,溶解性:Soluble in DMSO, hot methanol or mixture of methanol, chloroform.,CAS:22368-21-4,M.W:344.3
CAS No:22368-21-4
別名:5,7-Dihydroxy-3',4',6-trimethoxyflavone,NSC 122413
別包装品 別包装品あり
法規制等
保存条件 -20℃,暗所保存,乾燥状態(デシケータ内)で保存 法規備考
掲載カタログ

製品記事 AdipoGen社の低分子化合物
関連記事

Eupatilin

文献数: 0

説明文 Selective inhibitor of 5-lipoxygenase. Apoptosis and cell cycle arrest inducer. Anticancer compound. Inhibits ERK1/2, JNK, and NF-kappaB activation and expression of Raf-1 and Ras. Anti-proliferative compound. Anti-inflammatory and immunosuppressive. Anti-apoptotic compound in hepatocytes. Antioxidant. Antidiabetic. Enhances hepatic and plasma glucose metabolism and increases insulin secretion in type 2 diabetic mice. Inhibits angiogenesis by blocking STAT3 and VEGF expression. Neuroprotective. PI3K Class I, MKK3/6 and MKK4 inhibitor.。由来:Artemisia sp.,M.W.:344.3,純度:>98% (HPLC),化学式:C18H16O7,形状:solid,溶解性:Soluble in DMSO, hot methanol or mixture of methanol, chloroform.,CAS:22368-21-4,M.W:344.3
CAS No:22368-21-4
別名:5,7-Dihydroxy-3',4',6-trimethoxyflavone,NSC 122413
別包装品 別包装品あり
法規制等
保存条件 -20℃,暗所保存,乾燥状態(デシケータ内)で保存 法規備考
掲載カタログ

製品記事 AdipoGen社の低分子化合物
関連記事



目次に戻る

製品情報

商品コードAG-CN2-0432
品名Eupatilin
分子式C18H16O7
分子量344.3
CAS22368-21-4
構造式
純度≥98% (HPLC)
形状Pale yellow powder.
別名5,7-Dihydroxy-3',4',6-trimethoxyflavone; NSC 122413
特長
  • Selective inhibitor of 5-lipoxygenase.
  • Anti-proliferative and anticancer compound.
  • Apoptosis and cell cycle arrest inducer.
  • Inhibits ERK1/2, JNK, and NF-κB activation and expression of Raf-1 and Ras.
  • PI3K Class I, MKK3/6 and MKK4 inhibitor.
  • Inhibits angiogenesis by blocking STAT3 and VEGF expression.
  • Anti-inflammatory and immunosuppressive agent.
  • Antioxidant.
  • Antidiabetic. Enhances hepatic and plasma glucose metabolism and increases insulin secretion in type 2 diabetic mice.
  • Selective PPARα agonist.
  • Neuroprotective.
文献
  1. Selective inhibition of 5-lipoxygenase by natural compounds isolated from Chinese plants, Artemisia rubripes Nakai: Y. Koshihara, et al.; FEBS Lett. 158, 41 (1983)
  2. Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces apoptosis in human promyelocytic leukemia cells: H.J. Seo & Y.J. Surh; Mutat. Res. 496, 191-8 (2001)
  3. Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces cell cycle arrest in ras-transformed human mammary epithelial cells: D.H. Kim, et al.; Biochem. Pharmacol. 68, 1081 (2004)
  4. Eupatilin blocks mediator release via tyrosine kinase inhibition in activated guinea pig lung mast cells: J.Y Kim, et al.; J. Toxicol. Environ. Health A. 68, 2063 (2005)
  5. Eupatilin has an antiapoptotic action on hepatocytes, in contrast to apoptotic actions on other cells: T. Mine; J. Gastroenterol. 41, 818 (2006)
  6. Eupatilin protects gastric epithelial cells from oxidative damage and down-regulates genes responsible for the cellular oxidative stress: E.J. Choi, et al.; Pharm. Res. 25, 1355 (2008)
  7. Eupatilin inhibits H(2)O(2)-induced apoptotic cell death through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB: S. Lee, et al.; Food Chem. Toxicol. 46, 2865 (2008)
  8. Eupatilin, isolated from Artemisia princeps Pampanini, enhances hepatic glucose metabolism and pancreatic beta-cell function in type 2 diabetic mice: Y.J. Kang, et al.; Diabetes Res. Clin. Pract. 82, 25 (2008)
  9. Eupatilin exhibits a novel anti-tumor activity through the induction of cell cycle arrest and differentiation of gastric carcinoma AGS cells: E.J. Choi, et al.; Differentiation 77, 412 (2009)
  10. Eupatilin inhibits T-cell activation by modulation of intracellular calcium flux and NF-kappaB and NF-AT activity: Y.D. Kim, et al.; J. Cell Biochem. 108, 225 (2009)
  11. Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking STAT3-Mediated VEGF Expression: J.H. Cheong, et al.; J. Gastric Cancer 11, 16 (2011)
  12. The neuroprotective effect of eupatilin against ischemia/reperfusion-induced delayed neuronal damage in mice: M. Cai, et al.; Eur. J. Pharmacol. 689, 104 (2012)
  13. Eupatilin, a major flavonoid of Artemisia, attenuates aortic smooth muscle cell proliferation and migration by inhibiting PI3K, MKK3/6, and MKK4 activities: J.E. Son, et al.; Planta Med. 79, 1009 (2013)
  14. Massive elimination of multinucleated osteoclasts by eupatilin is due to dual inhibition of transcription and cytoskeletal rearrangement: J.-Y. Kim, et al.; Bone Rep. 3, 83 (2015)
  15. Identification of eupatilin from Artemisia argyi as a selective PPARα agonist using affinity selection ultrafiltration LC-MS: Y. Choi, et al.; Molecules 20, 13753 (2015)
  16. Eupatilin suppresses the allergic inflammatory response in vitro and in vivo: E-H. Song, et al.; Phytomed. 42, 1 (2018)


目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。